HHTM

Humans connect through communication, and hearing is a vital component of this process. Hearing loss, often associated with aging, can also be caused by genetics, ototoxicity, poor listening habits, ear disease, and other factors. It is frequently referred to as the invisible disease since it happens gradually and is not immediately noticeable until its effects become profound. However, sudden hearing

PALM BEACH GARDENS, FLORIDA — Leading hearing care retailer HearUSA today announced the opening of a new state-of-the-art Hearing Center of the Future in the Springtown area of San Marcos, Texas, at 199 Springtown Way, Unit 12. The opening is part of HearUSA’s initiative to expand access to Simply Excellent Hearing Care through the latest prescription and over-the-counter (OTC) hearing

CHADDS FORD, PENNSYLVANIA – CQ Partners has announced that Olympian and cancer survivor Chaunté Lowe will deliver the keynote address at the industry event, Reconnect ’25. Lowe will kick off Reconnect “with her positive, can-do attitude, empowering attendees throughout the event”. Reconnect ’25 will take place from February 27 to March 2, 2025, at the Omni Amelia Island Resort in

SEATTLE, WASHINGTON — Sound Pharmaceuticals has announced the completion of the Phase 3 clinical trial for SPI-1005, a novel anti-inflammatory treatment for Meniere’s Disease (STOPMD-3). SPI-1005, an oral capsule taken twice daily, is the only potential therapeutic to show significant improvement in hearing loss and tinnitus in Meniere’s Disease patients, as demonstrated in two previous studies. The STOPMD-3 study enrolled

Individuals with hearing loss often face significant challenges in understanding speech, especially in group conversations or noisy environments. These difficulties can lead to social isolation, withdrawal from activities, and reduced workplace participation. To address these issues, the National Acoustic Laboratories (NAL) is leveraging Apple Vision Pro’s mixed reality technology to enhance hearing health and communication accessibility. Introducing NALscribe AR, a

SAN FRANCISCO, CALIFORNIA – Concha Labs has announced the launch of their FDA-cleared Concha Sol™ Hearing Aids, an over-the-counter (OTC) solution offering personalized hearing profiles that users can set up from their iPhones without any appointments. Priced at $1,299 per pair, these hearing aids aim to address the common frustrations of inconvenience, high cost, and poor sound personalization experienced by

MILAN, ITALY — Amplifon S.p.A. has reported robust financial results for the first half of 2024, demonstrating significant growth in revenues and profitability. The company achieved consolidated revenues of €1.177 billion (approximately $1.28 billion USD), marking an 8% increase at constant exchange rates and a 5.7% increase at current exchange rates compared to the first half of 2023. This growth

COPENHAGEN, DENMARK – Oticon A/S has launched a clinical research partnership with the Division of Audiology at Detroit, Michigan-based Henry Ford Health, one of the leading integrated and academic healthcare systems in the United States. The collaboration aims to generate valuable insights into post-fitting outcomes and hearing aid user experiences. The Oticon Clinical Research Team will work with Henry Ford

Researchers have made significant progress in understanding how to reduce the harmful side effects of cisplatin, a common chemotherapy drug. Cisplatin is known for its effectiveness against various cancers but also for its severe side effects, especially hearing loss (ototoxicity) and kidney damage (nephrotoxicity). A recent study, led by a team from the National Institutes of Health (NIH) and other

EDEN PRAIRIE, MINNESOTA – Starkey has announced that the company has been awarded the prestigious 2024 National Access Award by the Hearing Loss Association of America (HLAA) last month. The award was presented at the recent HLAA Convention in Phoenix, Arizona and accepted by Dave Fabry, Ph.D., Starkey’s Chief Hearing Health Officer. The HLAA National Access Award was presented to Starkey in